BRIACELL THERAPEUTICS CORP (BCT.CA) Stock Balance Sheet
TSX:BCT - CA1079302081 - Common Stock
10.69 CAD
+0.59 (+5.84%)
| MRQ (2025-1-31) | 2024 (2024-7-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 862.10K | 21.25M | 41.04M | 57.27M | |||
| Cash Equivalents | 5.01M | N/A | N/A | N/A | N/A | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 2.15M | 2.79M | 18.90K | 24.10K | 12.60K | |||
| Other Current Assets | N/A | N/A | 5.68M | 1.28M | 516.90K | |||
| Total Current Assets | 7.16M | 3.65M | 26.95M | 42.35M | 57.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 342.50K | 388.20K | N/A | N/A | N/A | |||
| Investments And Advances | 454.40K | 418.50K | 0.00 | 0.00 | 0.00 | |||
| Intangibles | 192.20K | 199.80K | 215.10K | 230.30K | 245.60K | |||
| Other Non-Current Assets | 1.21M | 1.21M | N/A | N/A | N/A | |||
| Total Non-Current Assets | 2.20M | 2.22M | 215.10K | 230.30K | 245.60K | |||
| TOTAL ASSETS | 9.36M | 5.87M | 27.16M | 42.58M | 58.04M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accounts Payable | 5.23M | 7.46M | 1.80M | 941.10K | 556.80K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 5.23M | 7.46M | 1.80M | 941.10K | 556.80K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 26.00K | |||
| Other Non-Current Liabilities | 905.80K | 1.10M | 29.14M | 31.31M | 29.79M | |||
| Total Non-Current Liabilities | 529.90K | 793.50K | 29.14M | 31.31M | 29.82M | |||
| TOTAL LIABILITIES | 5.76M | 8.25M | 30.94M | 32.25M | 30.37M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -81.71M | -74.41M | -73.23M | -55.12M | -26.96M | |||
| Additional Paid In Capital | N/A | N/A | 7.42M | 5.23M | 2.18M | |||
| Minority Interest | -376.00K | -302.50K | N/A | N/A | N/A | |||
| Common Shares | 85.45M | 72.17M | 69.59M | 65.59M | 54.77M | |||
| Other Shareholders' Equity | -138.70K | -138.70K | -138.70K | -138.70K | -138.70K | |||
| Shares Outstanding | 294.70K | 121.90K | 106.60K | 103.50K | 101.80K | |||
| Tangible Book Value per Share | 11.57 | -21.18 | -37.47 | 97.61 | 269.41 | |||
| Total Shareholders' Equity | 3.60M | -2.38M | -3.78M | 10.33M | 27.67M | |||
| TOTAL LIABILITIES AND EQUITY | 9.36M | 5.87M | 27.16M | 42.58M | 58.04M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.00 | |||
| Current Ratio | 1.37 | 0.49 | 14.96 | 45.00 | 103.80 | |||
| Return On Assets (ROA) | -123.71% | -81.59% | -74.74% | -63.04% | -23.80% | |||
| Return On Equity (ROE) | -321.51% | N/A | N/A | -259.84% | -49.93% | |||
All data in USD , ROIC based on taxRate of 0.28